C0621
CI-994
≥98% (HPLC), HDAC Inhibitor, powder
別名:
4-アセチルアミノ-N-(2′-アミノフェニル)ベンズアミド, アセチルジナリン, タセジナリン
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
実験式（ヒル表記法）:
C15H15N3O2
CAS番号:
分子量:
269.30
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
製品名
CI-994, ≥98% (HPLC), powder
Quality Level
assay
≥98% (HPLC)
form
powder
color
off-white
solubility
DMSO: >10 mg/mL
storage temp.
room temp
SMILES string
CC(=O)Nc1ccc(cc1)C(=O)Nc2ccccc2N
InChI
1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20)
InChI key
VAZAPHZUAVEOMC-UHFFFAOYSA-N
Gene Information
Application
CI-994 has been used:
- as an histone deacetylase (HDAC) inhibitor to treat SUM229 and DT22 cells to study its effects
- as an HDAC inhibitor for screening in SPEL cells
- to study its effects on human myeloid and erythroid progenitors
Biochem/physiol Actions
CI-994は、化合物Dinaline(PD 104 208)のアセチル化誘導体です。白血病細胞と正常幹細胞に対して顕著な特異的活性を有する経口細胞分裂阻害薬です。非小細胞肺癌、膵臓癌、乳癌、結腸直腸癌を含む特定の腫瘍の併用療法に利用されます。ヒストン脱アセチル化酵素として作用します。CI-994は、細胞周期のG1期からS期の細胞をブロックします。16kDaのリン酸化タンパク質は、核コンパートメントに限定されます。16kDaの核リン酸化タンパク質の消失は、CI-994処理の直接的な影響と考えられるため、このリン酸化タンパク質の阻害がCI-994の作用機序において重要な役割を持つ可能性があります。
Orally available HDAC Inhibitor; CI-994 blocks cells in the G1-S phase of the cell cycle.
Features and Benefits
This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2
保管分類
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
資料
We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.
Establishing and characterizing a new primary effusion lymphoma cell line harboring Kaposi?s sarcoma-associated herpesvirus
Osawa M, et al.
Infectious Agents and Cancer, 11(1), 37-37 (2016)
S Prakash et al.
Investigational new drugs, 19(1), 1-11 (2001-04-09)
CI-994 (N-acetyl dinaline, PD 123654) is a novel oral agent active in a broad variety of murine and human tumor xenografts. While cytotoxic in the Brown Norway (BN) rat leukemia model, growth inhibition in other murine and human tumor xenografts
Ekaterina P Mochalova et al.
Scientific reports, 9(1), 10263-10263 (2019-07-18)
It is known that MuRF-1 and atrogin-1/MAFbx mRNA expression is increased in rat soleus muscle under unloading conditions. We aimed to determine the role of histone deacetylase 1 (HDAC1) in the activation of MuRF-1 and MAFbx expression in rat soleus